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Abstract: 
Tuberculosis (TB)is a bacterial infection caused by M. tuberculosis, also known as 
Mycobacterium Tuberculosis. The objective of this review is to determine the prevalence, 
diagnostic and prevention strategy between diabetes mellitus and tuberculosis. The selected 
studies were identified using PubMed database. The identified studies define lifestyle as 
important risk factor that may worsen the progression of the disease. This article also 
discussed about the prevalence of tuberculosis-diabetes mellitus (TB-DM) over a span of 8 
years. 
Introduction 
Tuberculosis is a contagious infection that affects lung most efficiently and can also transport 
through the blood or lymphatic system, TB bacteria can infect almost any part of the body, 
including lymph nodes, joints, kidneys, and bone. Tuberculosis can spread by droplets of 
bacteria released into the air by an infected person who coughs, sneezes, talks or sings
 
[1]
.Nowadays, Tuberculosis (TB) has become the most prevalent infectious disease in the 
world. Tuberculosis is by far the 7
th
 leading cause of the death worldwide, and experts predict 
that if the disease is not well controlled, it could become the world's leading cause of death 
by 2020. 
 
Figure 1     Countries with the highest burden of DM and TB  
 
People infected with TB will show symptoms of cough, fever, chest pain, loss of appetite, 
weight loss and others. TB can affect other parts of the body and shows symptoms that 
depend on the part it affects. For example, it can lead to meningitis if TB affected the brain or 
  
infection with the liver or kidney can cause filtration dysfunction, causing blood to enter the 
urine.People with immune deficiencies caused by the disease are most likely to develop TB. 
For instance, when a person is infected with AIDS, HIV suppresses the immune system, 
preventing it from usually suppressing TB bacteria. 
Furthermore, people with diabetes, certain cancers, malnutrition, kidney disease, cancer 
treatments such as chemotherapy or many others can have an increased risk to get 
tuberculosis.Tuberculosis is common in particular geographic regions, ethnic groups, or age 
groups. However, it can affect all age groups and all parts of the world. 
People with diabetes are three times more likely to develop tuberculosis. In the interaction 
between tuberculosis and diabetes, the effect of diabetes on tuberculosis is more life-
threatening. Therefore, the World Health Organization (WHO) defines diabetes as a risk 
factor for tuberculosis
[2]
. The main reason for the prevalence of tuberculosis in diabetic 
patient is because the bacteria can grow and multiply easily in the high-sugar environment 
and often lack vitamins A and B, thus weaken the resistance of respiratory tract, which is 
conducive to the infection and development of the bacteria. Infected patients with 
tuberculosis, due to symptoms of poisoning and the consumption of nutrients, affect the 
normal play of islet, causing islet cell malnutrition and atrophy, leading to diabetes. 
Diabetes is closely related to tuberculosis. In recent years, diabetes has been significantly 
increased with tuberculosis, which has become a clinical concern. When the two diseases 
coexist, the tuberculosis is complicated and difficult to treat. As the incidence of diabetes and 
tuberculosis continues to increase, the prevalence of tuberculosis has gradually increased, and 
research on the correlation between the two has increased. Therefore, our objective of this 
study is to better understand the relationship between diabetes and tuberculosis prevalence, 
diagnosis and prevention.  
Methodology 
By using PubMed database, the author has found 3842 articles with the keywords of 
Tuberculosis and Diabetes which is ("tuberculosis"[MeSH Terms] OR "tuberculosis"[All 
Fields]) AND ("diabetes mellitus"[MeSH Terms] OR ("diabetes"[All Fields] AND 
"mellitus"[All Fields]) OR "diabetes mellitus"[All Fields]). The articles publishedare selected 
for last ten 10 years, which was from January 2009 to July 2019. The articles that have been 
chosen are published in the year 2010 and 2017, respectively. All article type such as clinical 
trial and review are included. The articles chosen are written in English. Among them, the 
author has chosen two 2 articles which are most related to the topic. The chosen articles are 
based upon prevalence, diagnostics and prevention of Tuberculosis and Diabetes Mellitus.  
 
 
  
 
Database Search Strategy Results 
Pubmed Search field: All field 
Search item: ("tuberculosis"[MeSH Terms] OR 
"tuberculosis") AND ("diabetes mellitus"[MeSH 
Terms] OR ("diabetes" AND "mellitus") OR 
"diabetes mellitus") 
Limits used: English text only and published 
within the last 10 years (1997 to present). 
3842 
 
 
Literature review 
Table 1: Studies assessing the effect of diabetes mellitus on treatment failure and death in 
patients treated for tuberculosis (TB) 
[3] 
Characteri- 
stics 
Treatment Failure Mortality 
Year 2003 2007 2002 2003 2008 2009 2009 
Location Egypt Indonesia Maryland, 
USA 
Congo Sao Paulo, 
Brazil 
Maryland, 
USA 
Taiwan 
Setting TB 
treatment 
centres 
Outpatient 
clinics 
Outpatient 
clinic 
University 
hospital 
Urban TB patients 
in three 
countries 
Teaching 
hospital 
Type of 
study 
Case-
control 
study 
assessing 
risk 
factors 
for 
treatment 
failure, 
matched 
for sex 
and 
centre 
Prospective 
cohort study 
of new 
pulmonary 
TB patients 
Retrospective 
cohort study 
of culture-
confirmed 
TB patients 
Case-control 
study using 
chart review 
Retrospective 
study of all 
TB-related 
deaths using 
death 
certificates, 
surveillance 
data, hospital 
records 
Retrospective 
cohort study 
of culture-
positive TB 
patients 
Retrospect-
ive study of 
culture-
positive 
pulmonary 
TB patients 
  
Participants
(n) 
119 
cases, 
119 
controls 
634 cases 139 cases 32 cases, 100 
controls 
416 cases 297 cases 217 cases 
 
 
 
Table 2: Review on several characteristics comparing article 1 and article 2. 
Characteristics Article 1
[2] 
Article 2
[1] 
Prevalence of 
Diabetes 
Mellitus and 
Tuberculosis 
The global prevalence of Diabetes 
Mellitus: 
The number of diabetes patients 
was 171 million in 2000. It is 
predicted to increase 214.04% to 
257.31% by 2030 which is 366 
million to 440 million, with three-
quarters of diabetes patients living 
in low-income countries 
 
The global prevalence of 
Tuberculosis:  
N/A 
 
Prevalence of Tuberculosis-
Diabetes Mellitus: 
Higher in low-income and middle-
income countries. 
The global prevalence of Diabetes 
Mellitus: 
The number of people who are 
suffering from Diabetes Mellitus 
among adults has increased by 20% 
in less than 30 years, and Diabetes 
Mellitus is predicted to reach 642 
million worldwide by 2040 with 
most (80%) of the patients living in 
low and middle-income countries 
where TB is also endemic.  
 
The global prevalence of 
Tuberculosis:  
N/A 
 
Prevalence of Tuberculosis-
Diabetes Mellitus: 
Higher in low- and middle-income 
countries where Tuberculosis and 
Diabetes Mellitus are endemic. 
 
Countries 
having high 
incidence of 
Tuberculosis 
South Africa, Swaziland, Uganda, 
Kenya, Cabo Verde The Gambia, 
Nigeria, Zimbabwe, Western 
Sahara, Ethiopia, Cambodia, 
China, India, Brazil, Bangladesh, 
Indonesia and Russia. 
  
and Diabetes 
Mellitus 
 
Taiwan. 
Type of study Chest radiograph survey, 
retrospective cohort, cross-
sectional study, longitudinal 
cohort study, case-control study, 
population-based cohort and 
matched case-control study. 
 
Retrospective-based cohort 
Diabetes 
Mellitus as a 
risk factor for 
Tuberculosis 
 
Diabetes Mellitus patients are 
more likely to develop multidrug-
resistant Tuberculosis than those 
without Diabetes Mellitus. 
Diabetes Mellitus increases the risk 
of Tuberculosis by three-fold. 
 
Co-occurrence of Diabetes Mellitus 
with other host characteristics can 
further synergise Tuberculosis risk 
among Diabetes Mellitus patients, 
as suggested for Diabetes Mellitus 
plus smoking, micro and 
macrovascular complications of 
DM, and even their social 
environment. 
*N/A=Not available 
 
Discussion 
In the introduction, we mentioned that the existence of diabetes and tuberculosis is mutual. 
From the literature reviews that we chose, we also found that the tuberculosis rate in patients 
with diabetes was 23.5%, while the incidence of diabetes in patients with tuberculosis was 
12.4%
[4]
. However, there was a low uptake of a diagnostic evaluation for tuberculosis and 
confined to the patients that had evident symptoms of TB. So, only diabetic patients 
suspected of tuberculosis will be actively referred. Several programs have also been proposed 
to screen early TB-DM. Doctors must be well-trained that the DM patients receive routine 
TB screening to carry out other diabetes-associated complications. Moreover, user-fees for 
the X-ray limit the number of screenings. Based on this problem, cost-free or subsidised will 
reduce the financial burden, encourage patients to undergo screening and increase the uptake 
of TB testing. Screening for diabetes in TB patients is best done at the start of TB treatment 
  
and registration. Low-cost diabetes testing is recommended, although the results may be 
slightly skewed, patients are more likely to agree that it is cheap. The laboratories or at the 
provider clinics provide these tests with the assurance of interventions to obtain data on DM 
screening as part of the TB surveillance system. Integrated delivery units provide a solution 
for DM-screening, TB diagnosis and TB-DM treatment in a facility that can capture data with 
supporting systems and monitoring results.  
 
Figure 2 The prevalence of TB-DM among TB cases increased over 8 years 
The results of the study indicate that patients with TB-DM have a higher risk of adverse 
tuberculosis outcomes, including delayed mycobacterial clearance, relapse and reinfection, 
treatment failure, and even death
[2]
. Two factors are prime suspects, poor glucose control and 
differences in antibiotic levels of plasma anti - mycoplasma bacteria. Based on the problems 
stated, we can bring out another question: How to prevent the development of tuberculosis in 
a patient with diabetes?  
Therefore, for patients diagnosed with diabetic tuberculosis, the control of blood glucose and 
effective anti-tuberculosis drugs are the key points and difficulties in the treatment of this 
disease, as well as the key to prevent the emergence of drug-resistant tuberculosis. Active 
control of blood glucose is the key to the treatment of diabetic tuberculosis. Meanwhile, early 
diagnosis of tuberculosis, early adequate and reasonable anti-tuberculosis treatment, 
strengthening blood glucose monitoring during treatment, and timely evaluation of the 
treatment effect by reviewing chest radiographs and sputum bacteria. For people with poor 
glycaemic control, they should consider an appropriate extension of course to 1 year or more. 
If it progresses to multidrug-resistant tuberculosis (Mdr-tb), it is more contagious, more 
difficult to treat, and the failure rate and mortality are higher. It is essential to develop an 
appropriate and effective treatment plans for Mdr-tb, and also strengthen the management of 
patients. These methods are essential to interrupt its transmission. 
Conclusion 
The high prevalence of diabetes mellitus in low- and middle-income countries where 
tuberculosis is endemic has become one of the issues that should be targeted by the related 
 
  
department. Prevalence, diagnostics and prevention of tuberculosis and diabetes mellitus are 
the topics that needed to be emphasized. Upon the high prevalence of diabetes mellitus and 
tuberculosis, the author has mentioned some actions which are necessary forpreventing the 
occurrence of tuberculosis and diabetes mellitus that will be stated below. Those actions need 
to be paid attention by related department so that the prevention for TB-DM can be controlled 
in well-manner. 
Furthermore, the author has also stated the relationship between diabetes mellitus and 
tuberculosis. People who are suffering from chronic diseases such as diabetes mellitus will 
have a weaker immune system
[6]
. Therefore, they are more likely to progress from latent to 
active tuberculosis. In the research, it was found that the risk of tuberculosis is related to the 
severity of diabetes mellitus. Patients who needed more than 40 units of insulin per day havea 
double chance to develop Tuberculosis than those with lower doses.  
There are several precautions that are needed to be taken note by TB-DM patients. 
Poorly controlled diabetes can lead to several complications, including increased 
susceptibility to infection. For example, infection caused by Mtb. Therefore, diabetes patients 
need to have regular diabetes control 
[7]
 including strict control on their diet and carry out a 
healthy lifestyle such as exercise regularly and sleep according to time. Besides, the author 
has also mentioned that diabetes mellitus can increase the risk of successful LTBI in close 
contacts which can facilitate the progression from LTBI to TB. In the article, the author has 
also mentioned that DM-TB patients have a higher frequency of lower lung lobe infiltrates 
where Mtb would implant during inhalation. One should further themselves from high 
infection area where Mtb are endemic.  
As we know that infections are the cause of worsening diabetic control, but the drugs 
taken by diabetes patients to treat tuberculosis may also weaken the glycaemic control of the 
patients. In the article, the author has also brought up some facts that need to be taken serious. 
First, overlapping toxicities when treating tuberculosis and diabetes mellitus must be handled 
carefully to avoid subsequent action to the patients
[3]
. As an example, isoniazid is a drug 
which is used to treat active tuberculosis infections. However, it might cause peripheral 
neuropathy. Therefore, pyridoxine should be given at the same time to avoid such incidence.  
In addition, rifampicin is a potent inducer, which is a host of metabolising enzymes 
can accelerate the metabolism of drugs given with rifampicin. It can cause hyperglycaemia 
when treated with oral hypoglycaemic drugs directly or indirectly and leading to reduced 
treatment effects. For example, Sulfonylureas is an oral hypoglycaemic drug which is usually 
used for NIDDM patients. Other treatment such as rosiglitazone and repaglinide should also 
be paid more attention when treating with rifampicin. This is because rifampicin can reduce 
the concentrations of the mentioned drugs by 54% and 31% respectively.  
  
Tuberculosis is an infectious disease which can be transmitted through the air 
[5]
. Thus, 
one needs to be cautious when exposing to a high risk area. Wearing a mask would be an 
ideal way to prevent infection. However, the best preventing way is to avoid an area with the 
high spreading of tuberculosis, especially diabetes patients. They need to have full protection 
from tuberculosis in order to prevent any infection.  
 As a conclusion, TB-DM patients need to pay more attention to their lifestyle. All the 
risk factors should be avoided to prevent any incidences or to worsening of the disease. The 
associated department should also educate the public on the prevention of diseases. 
Campaign and social media are the easiest and effective way of reducing the prevalence of 
tuberculosis and diabetes mellitus.   
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